14
report
ESG Investing: Beyond the Standards
In the face of increased pressure from investors for information and the complexity of disclosing t
he relevant data, the public and private sectors agree on the need to simplify environmental, social and governance (ESG) reporting.
+ Read More
report
Sharing the Cost: Accelerating Water Resilience through Infrastructure Finance in California
Beyond the intensifying drought and widening infrastructure inefficiencies, there are billions of d
ollars worth of unmet operation and maintenance costs and system improvements currently to be found in the State Water Project and Central Valley Project,
+ Read More
article
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill.
article
FinTech in Focus — December 27, 2022
In This Newsletter
US Africa Summit
Household Crypto Usage
Takeaways from FTX’s Collapse
article
FinTech in Focus — December 13, 2022
In This Newsletter
Unlocking the Power of Blockchain: Real World Use Cases
The Next FinTech Unicorn
: Investment Opportunities in FinTech
+ Read More
article
The Milken Institute Future of Health Summit Opens December 6 in Washington, DC
Washington, DC (December 6, 2022) – Beginning today, the 2022 Milken Institute Future of Health Summ
it will convene in person for the first t
+ Read More
video
December 6 at 2:00 pm EST | Improving Health Equity in Rare Diseases Research
People with rare diseases face many barriers and inequities in accessing diagnosis, treatment, and
comprehensive care. This burden is even greater among marginalized communities with rare diseases.
+ Read More
video
December 6 at 2:00 pm EST | Innovation in Biomarker Development and Deployment
Validated biomarkers are an essential and often under-appreciated tool for detecting and treating
diseases, improving drug development, and informing regulatory decision making.
+ Read More
video
December 6 at 3:30 pm EST | Time=Lives and Building the Clinical Trial Enterprise of the Future
This session will open with a Time=Lives Talk by Casey McPherson, Co-Founder and Chief Innovation
Officer, Everlum Bio and Founder and President, To Cure A Rose Foundation, followed by a panel discussion on Building the Clinical Trial Enterprise of the
+ Read More
video
December 6 at 3:30 pm EST | Time=Lives and Overcoming Challenges to Drug Repurposing
New drugs can take more than a decade to develop and get to market.
video
December 6 at 7:15 pm EST | Future of Health Summit Dinner | A Commitment to Accelerating Cures: The Future of Biomedical Innovation
The new year will begin with fresh leadership at several of the nation's top scientific agencies.
Hear from Dr. Bertagnolli and Dr.
+ Read More
video
December 7 at 10:30 am EST | Maximizing the Potential of the New Advanced Research Projects Agency for Health (ARPA-H)
This session will open with a conversation with Representative Anna Eshoo, followed by a panel dis
cussion on ARPA-H.
+ Read More